| Chronic Obstructive Pulmonary Disease |
1 |
1 |
| Clinical Research |
0 |
0.66 |
| Chronic Bronchitis |
0 |
0.38 |
| Healthcare and Medical Technology |
0 |
0.33 |
| Bronchitis |
0 |
0.27 |
| Illinois |
0 |
0.27 |
| Smoking |
0 |
0.27 |
| Arterial Blood Gases |
0 |
0.23 |
| Blood |
0 |
0.2 |
| Lung |
0 |
0.2 |
| Severe COPD |
0 |
0.2 |
| Complete Blood Count |
0 |
0.19 |
| Inhaled Corticosteroid |
0 |
0.14 |
| Metered-Dose Inhaler (MDI) |
0 |
0.14 |
| Adverse Effects |
0 |
0.13 |
| Bacteria |
0 |
0.13 |
| Clinical Guidelines |
0 |
0.13 |
| Corticosteroids |
0 |
0.13 |
| Heart |
0 |
0.13 |
| Inhalers |
0 |
0.13 |
| Sleep |
0 |
0.13 |
| Tobacco Cessation |
0 |
0.13 |
| Weight Loss |
0 |
0.13 |
| Asthma |
0 |
0.12 |
| Otolaryngology |
0 |
0.11 |
| Chest X-ray |
0 |
0.09 |
| Peripheral Edema |
0 |
0.09 |
| Patient Safety |
0 |
0.08 |
| Allergy |
0 |
0.07 |
| Bronchodilator |
0 |
0.07 |
| Cough |
0 |
0.07 |
| Depression History |
0 |
0.07 |
| Dyspnea |
0 |
0.07 |
| Edema |
0 |
0.07 |
| Electrocardiogram (ECG) |
0 |
0.07 |
| Eosinophilia |
0 |
0.07 |
| Eosinophils |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Generics |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Immunization |
0 |
0.07 |
| Mouth |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Patient Confidentiality |
0 |
0.07 |
| Patient History |
0 |
0.07 |
| Prisons |
0 |
0.07 |
| Pulmonary Function Test |
0 |
0.07 |
| Pulmonary Rehabilitation |
0 |
0.07 |
| Sinus |
0 |
0.07 |
| Thorax |
0 |
0.07 |
| Weight Management |
0 |
0.07 |
| Depression |
0 |
0.06 |